Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer indications, including small cell lung, colorectal...
241 insider purchases on record · latest filing 2010-03-29.
Insiders have also filed 18 sale transactions at PARD.